Medicare GLP-1 Bridge
Is Foundayo covered by Medicare?
Yes — all formulations of Foundayo are covered for weight loss at a $50 monthly copay for eligible Medicare Part D members under the GLP-1 Bridge pilot, from July 1, 2026 through December 31, 2027.
See where you land in one minute. Start the free check →
Copay$50/month, all doses
Covered drugsWegovy, Zepbound KwikPen, Foundayo
RequiresMedicare Part D enrollment
Program windowJul 1, 2026 – Dec 31, 2027
Foundayo is one of the three GLP-1 weight-loss medications in the Bridge program, alongside Wegovy and the Zepbound KwikPen. The copay is a flat $50 a month at any dose.
Eligibility depends on Medicare Part D plus a qualifying BMI and, below a BMI of 35, a qualifying condition. Run the free check to see where you land.
Related questions
What does Foundayo cost with Medicare?
$50 a month for eligible Bridge participants, at any dose.
Not sure if you qualify?
Check your eligibility →